Page last updated: 2024-09-03

lvv-hemorphin-7 and naltrexone

lvv-hemorphin-7 has been researched along with naltrexone in 1 studies

Compound Research Comparison

Studies
(lvv-hemorphin-7)
Trials
(lvv-hemorphin-7)
Recent Studies (post-2010)
(lvv-hemorphin-7)
Studies
(naltrexone)
Trials
(naltrexone)
Recent Studies (post-2010) (naltrexone)
590148,7451,2282,642

Protein Interaction Comparison

ProteinTaxonomylvv-hemorphin-7 (IC50)naltrexone (IC50)
Cytochrome P450 2D6Homo sapiens (human)1
Delta-type opioid receptorMus musculus (house mouse)0.0051
Delta-type opioid receptorRattus norvegicus (Norway rat)0.0063
Kappa-type opioid receptorMus musculus (house mouse)0.006
Mu-type opioid receptorRattus norvegicus (Norway rat)0.0005
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.0005
Mu-type opioid receptorHomo sapiens (human)0.006
Delta-type opioid receptorHomo sapiens (human)0.0319
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.0093
Kappa-type opioid receptorHomo sapiens (human)0.0377
Mu-type opioid receptorMus musculus (house mouse)0.0076
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.0004

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebinger, G; FourniƩ-Zaluski, MC; Michotte, Y; Sarre, S; Stragier, B; Vanderheyden, P; Vauquelin, G1

Other Studies

1 other study(ies) available for lvv-hemorphin-7 and naltrexone

ArticleYear
Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat.
    Journal of neurochemistry, 2004, Volume: 90, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Hemoglobins; Imidazoles; Male; Methionine; Microdialysis; Naltrexone; Narcotic Antagonists; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonic Acids; Tetrazoles; Time Factors

2004